CSBR:NASDAQ
Champions Oncology Inc
US$4,68
arrow_downward
-0,53%(-0,025) 1D
16 ພ.ຈ., 16 ໂມງ 0 ນາທີ 00 ວິນາທີ GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSBR...
Open
US$4,68
High
US$4,68
Low
US$4,68
Mkt. cap
65,07 ລ້ານ
Avg. vol.
8,15 ພັນ
Volume
644,00
52-wk high
US$8,31
52-wk low
US$4,52
EPS
US$-0,08
Beta
0,47
Shares outstanding
13,92 ລ້ານ
No. of employees
217
Open
US$4,68
High
US$4,68
Low
US$4,68
Mkt. cap
65,07 ລ້ານ
Avg. vol.
8,15 ພັນ
Volume
644,00
52-wk high
US$8,31
52-wk low
US$4,52
EPS
US$-0,08
Beta
0,47
Shares outstanding
13,92 ລ້ານ
No. of employees
217
News stories
From web sources and news partners
Investing.com
·
9 ນາທີກ່ອນ
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.41%
The Motley Fool
·
1 ຊົ່ວໂມງກ່ອນ
Here's How the S&P 500 Has Moved the Day After Each of Nvidia's Last 12 Reports
24/7 Wall St.
·
34 ນາທີກ່ອນ
S&P 500 Closes Down 2% as Nasdaq Leads Broad Market Lower
ChartMill
·
1 ຊົ່ວໂມງກ່ອນ
S&P 500 Top Movers: Gainers and Losers for Nov. 16, 2026
Profile
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist. Wikipedia
About Champions Oncology Inc
CEO-
Employees217
Founded2007
HeadquartersHackensack, ນິວເຈີຊີ, ສະຫະລັດ
SectorHealth Care
Industry-
Websitechampionsoncology.com